These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36130981)

  • 1. Diagnostic features and management options for duodenal neuroendocrine neoplasms: a retrospective, multi-centre study.
    Mandair D; Kamieniarz L; Pizanias M; Weickert MO; Narayan A; O'Mahony LF; Caplin M; Ramage J; Prachalias A; Srirajaskanthan R; Toumpanakis C
    Sci Rep; 2022 Sep; 12(1):15762. PubMed ID: 36130981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duodenal neuroendocrine neoplasms on enhanced CT: establishing a diagnostic model with duodenal gastrointestinal stromal tumors in the non-ampullary area and analyzing the value of predicting prognosis.
    Feng N; Chen HY; Lu YF; Pan Y; Yu JN; Wang XB; Deng XY; Yu RS
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):15143-15157. PubMed ID: 37634206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of Duodenal Neuroendocrine Tumors: An Italian Multi-center Experience.
    Massironi S; Campana D; Partelli S; Panzuto F; Rossi RE; Faggiano A; Brighi N; Falconi M; Rinzivillo M; Delle Fave G; Colao AM; Conte D
    Ann Surg Oncol; 2018 Oct; 25(11):3200-3206. PubMed ID: 30054824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duodenal neuroendocrine neoplasms: a still poorly recognized clinical entity.
    Rossi RE; Rausa E; Cavalcoli F; Conte D; Massironi S
    Scand J Gastroenterol; 2018; 53(7):835-842. PubMed ID: 29726295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy.
    Rossi RE; Milanetto AC; Andreasi V; Campana D; Coppa J; Nappo G; Rinzivillo M; Invernizzi P; Modica R; David A; Partelli S; Lamberti G; Mazzaferro V; Zerbi A; Panzuto F; Pasquali C; Falconi M; Massironi S;
    J Endocrinol Invest; 2021 Oct; 44(10):2227-2234. PubMed ID: 33651317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of lymph node ratio in recurrence after curative surgery for pancreatic endocrine tumours.
    Ricci C; Casadei R; Taffurelli G; Buscemi S; D'Ambra M; Monari F; Santini D; Campana D; Tomassetti P; Minni F
    Pancreatology; 2013; 13(6):589-93. PubMed ID: 24280574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-functional duodenal neuroendocrine neoplasia in the proximal duodenum--case reports and proposal for a "high-risk-/low-risk-concept" in the decision for local endoscopic therapy].
    Scheerer F; Schmitt W
    Z Gastroenterol; 2013 Nov; 51(11):1240-50. PubMed ID: 24243571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant pancreatic neuroendocrine tumour: lymph node ratio and Ki67 are predictors of recurrence after curative resections.
    Boninsegna L; Panzuto F; Partelli S; Capelli P; Delle Fave G; Bettini R; Pederzoli P; Scarpa A; Falconi M
    Eur J Cancer; 2012 Jul; 48(11):1608-15. PubMed ID: 22129889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of recurrence after resection of well-differentiated non-functioning pancreatic neuroendocrine tumors.
    Tan QQ; Wang X; Yang L; Chen YH; Tan CL; Zhu XM; Ke NW; Liu XB
    Medicine (Baltimore); 2020 Jun; 99(24):e20324. PubMed ID: 32541455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management and Prognosis of Localized Duodenal Neuroendocrine Neoplasms.
    Gay-Chevallier S; de Mestier L; Perinel J; Forestier J; Hervieu V; Ruszniewski P; Millot I; Valette PJ; Pioche M; Lombard-Bohas C; Subtil F; Adham M; Walter T
    Neuroendocrinology; 2021; 111(8):718-727. PubMed ID: 32335556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic treatment of sporadic small duodenal and ampullary neuroendocrine tumors.
    Gincul R; Ponchon T; Napoleon B; Scoazec JY; Guillaud O; Saurin JC; Ciocirlan M; Lepilliez V; Pioche M; Lefort C; Adham M; Pialat J; Chayvialle JA; Walter T
    Endoscopy; 2016 Nov; 48(11):979-986. PubMed ID: 27494453
    [No Abstract]   [Full Text] [Related]  

  • 12. Surgical resection for duodenal neuroendocrine neoplasia: Outcome, prognostic factors and risk of metastases.
    Nießen A; Bergmann F; Hinz U; Schimmack S; Hackert T; Büchler MW; Strobel O
    Eur J Surg Oncol; 2020 Jun; 46(6):1088-1096. PubMed ID: 32088004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
    Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
    Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A "Watch and Wait" Strategy Involving Regular Endoscopic Surveillance Is Safe for Many Patients with Small, Sporadic, Grade 1, Non-Ampullary, Non-Functioning Duodenal Neuroendocrine Tumours.
    Exarchou K; Moore AR; Smart HL; Duckworth CA; Howes N; Pritchard DM
    Neuroendocrinology; 2021; 111(8):764-774. PubMed ID: 32937631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Recurrence Between Pancreatic and Duodenal Neuroendocrine Neoplasms After Curative Resection: A Single-Institution Analysis.
    Masui T; Sato A; Nakano K; Uchida Y; Yogo A; Anazawa T; Nagai K; Kawaguchi Y; Takaori K; Uemoto S
    Ann Surg Oncol; 2018 Feb; 25(2):528-534. PubMed ID: 29164413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Role of Examined and Positive Lymph Nodes after Distal Pancreatectomy for Non-Functioning Neuroendocrine Neoplasms.
    Guarneri G; de Mestier L; Landoni L; Partelli S; Gaujoux S; Andreasi V; Nessi C; Dokmak S; Fontana M; Dousset B; Ruszniewski P; Bassi C; Falconi M; Sauvanet A
    Neuroendocrinology; 2021; 111(8):728-738. PubMed ID: 32585667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of the Ki67 index for lymph node metastasis of small non-functioning pancreatic neuroendocrine neoplasms.
    Masui T; Sato A; Nakano K; Uchida Y; Yogo A; Anazawa T; Nagai K; Kawaguchi Y; Takaori K; Uemoto S
    Surg Today; 2019 Jul; 49(7):593-600. PubMed ID: 30838442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The number of positive nodes accurately predicts recurrence after pancreaticoduodenectomy for nonfunctioning neuroendocrine neoplasms.
    Partelli S; Javed AA; Andreasi V; He J; Muffatti F; Weiss MJ; Sessa F; La Rosa S; Doglioni C; Zamboni G; Wolfgang CL; Falconi M
    Eur J Surg Oncol; 2018 Jun; 44(6):778-783. PubMed ID: 29610023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Number of Positive Lymph Nodes Is Superior to LNR and LODDS for Predicting the Prognosis of Pancreatic Neuroendocrine Neoplasms.
    Gao B; Zhou D; Qian X; Jiang Y; Liu Z; Zhang W; Wang W
    Front Endocrinol (Lausanne); 2021; 12():613755. PubMed ID: 33746899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duodenal neuroendocrine neoplasms with unexpectedly aggressive behaviour: Challenging the "watch and wait" approach.
    Ratnayake GM; Srirajaskanthan R; Luong T; Gnanasegaran G; Toumpanakis C
    J Neuroendocrinol; 2022 Jan; 34(1):e13067. PubMed ID: 34914146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.